Market Overview

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Related VIVO
Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI
Meridian Bioscience Down to Strong Sell - Analyst Blog
Related TRIB
Barron's Recap: The Tired Bull
Trinity Biotech (TRIB) Falls: Stock Goes Down 5.4% - Tale of the Tape

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin.

The trailing-twelve-month operating margin at SurModics (NASDAQ: SRDX) is 32.12%. SurModics had $28.43 million in total cash for the latest quarter.

The trailing-twelve-month operating margin at Meridian Bioscience (NASDAQ: VIVO) is 30.48%. Meridian Bioscience's ROE for the same period is 25.63%.

The trailing-twelve-month operating margin at Trinity Biotech plc (NASDAQ: TRIB) is 19.54%. Trinity Biotech's revenue for the same period is $86.08 million.

The trailing-twelve-month operating margin at Quidel (NASDAQ: QDEL) is 10.92%. Quidel's PEG ratio is 5.12.

Posted-In: Diagnostic Substances Industry Operating Margin small-capTrading Ideas

 

Most Popular

Related Articles (QDEL + SRDX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free